Publication: A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata
Issued Date
2020-01-01
Resource Type
ISSN
14711753
09546634
09546634
Other identifier(s)
2-s2.0-85087024791
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Dermatological Treatment. (2020)
Suggested Citation
Poonkiat Suchonwanit, Chaninan Kositkuljorn, Tippapai Mahasaksiri, Kanchana Leerunyakul A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. Journal of Dermatological Treatment. (2020). doi:10.1080/09546634.2020.1773384 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/58254
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata
Other Contributor(s)
Abstract
© 2020, © 2020 Taylor & Francis Group, LLC. Background: Topical corticosteroids (TC) and/or intralesional corticosteroids (IC) are considered first-line treatments for patch-type alopecia areata (AA). However, the efficacies of TC monotherapy, IC monotherapy, and combined topical and intralesional corticosteroids (CC) in patients with AA have never been compared. Objective: To evaluate and compare the efficacy and tolerability of 3 corticosteroid treatments (TC, IC, and CC) in patients with AA. Methods: A study of patients with AA who received TC, IC, or CC was conducted. Outcomes including initial hair regrowth (25% regrowth), significant hair regrowth (>80% regrowth), and adverse events were statistically compared. Cox proportional hazards regression analysis was used to identify factors that influence the treatment response. Results: One hundred and forty-eight patients were eligible for analysis. The response rates of initial and significant hair regrowth were comparable among 3 treatment groups. Multivariate analysis revealed that an AA treatment duration of longer than 6 months was associated with a lower probability of significant hair regrowth. A small proportion of patients experienced adverse effects. Conclusion: The 3 corticosteroid treatment regimens are effective, safe, and show no significant differences in treatment outcomes. However, an AA duration longer than 6 months portends a lack of significant hair regrowth.